Genomic Biotech Financials

BSE: 539206

₹30.20

₹0.00 (0.00%)

As on 09-Sep-2026IST

Market cap

₹9 Cr

Revenue (TTM)

₹0 Cr

P/E Ratio

439.3

P/B Ratio

2.3

Div. Yield

0 %

Annual
Quarterly

Income Statement (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Operating Revenue	0.22	0.84	0.17	2.72	0.07	0.21
Total Income	0.22	0.85	0.17	2.77	0.15	0.21
Total Expenditure	0.18	0.40	0.15	1.84	0.45	0.34
EBITDA	0.04	0.44	0.02	0.88	-0.38	-0.14
Depreciation	0.00	0.00	0.00	0.01	0.08	0.19
EBIT	0.03	0.44	0.01	0.87	-0.46	-0.33
Interest	--	0.00	0.00	0.00	0.04	0.18
Other Income	--	0.00	0.00	0.04	0.08	0.00
Exceptional Items	--	--	--	-0.26	0.42	--
Profit before Tax	0.03	0.44	0.02	0.65	0.00	-0.50
Provision for Tax	0.01	0.09	0.00	0.00	0.01	0.06
Profit after Tax	0.02	0.36	0.02	0.65	-0.01	-0.56

Liabilities (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Shareholder's Funds	3.93	3.90	3.54	3.53	2.88	4.49
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	0.00	0.00	0.00	0.70	2.25
Current Liabilities	0.32	0.46	0.79	0.89	0.21	0.87
Total Liabilities	4.25	4.36	4.33	4.42	3.80	7.62

Assets (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Non-Current Assets	1.55	1.73	1.42	1.84	2.66	7.45
Current Assets	2.70	2.62	2.91	2.58	1.14	0.16
Total Assets	4.25	4.36	4.33	4.42	3.80	7.62
Total Debt*	--	--	--	--	--	1.55
Net Current Assets	2.38	2.16	2.12	1.68	0.92	-0.71
Contingent Liabilities	--	--	--	--	--	--

Cashflow (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Cash From Operating Activities	--	0.03	-0.02	-0.78	-2.13	1.48
Cash Flow from Investing Activities	--	0.01	-0.02	1.52	3.67	-1.58
Cash from Financing Activities	--	--	--	-0.70	-1.55	0.07
Net Cash Inflow / Outflow	--	0.04	-0.04	0.04	-0.01	-0.03

Financials Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Adjusted EPS (₹)	0.07	1.17	0.05	2.12	-0.03	-1.83
Cash EPS (₹)	0.07	1.17	0.05	2.15	0.25	-1.21
Adjusted Book Value (₹)	12.91	12.76	11.60	11.55	9.42	14.69
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	--	0.09	-0.07	-2.55	-6.97	4.86
Free Cash Flow per Share (₹)	--	0.07	-0.06	-3.28	-4.51	-0.50

Profitability Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
ROCE (%)	--	11.87	0.45	20.35	0.93	-5.14
ROE (%)	0.53	9.57	0.43	20.24	-0.25	-11.73
ROA (%)	0.49	8.20	0.35	15.78	-0.16	-7.19
EBIT Margin (%)	14.35	51.80	8.66	32.09	-654.36	-156.50
Net Margin (%)	9.72	41.97	9.11	23.44	-6.04	-264.95
Cash Profit Margin (%)	0.00	42.50	9.86	24.10	106.31	-177.74

Growth Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Revenue Growth (%)	-72.27	411.25	-93.94	3,758.23	-66.09	-75.42
EBIT Growth (%)	-90.43	2,957.90	-98.36	289.18	-41.80	-186.83
Net Profit Growth (%)	-91.46	2,245.51	-97.66	7,040.47	98.33	-295.48
EPS Growth (%)	-91.47	2,245.67	-97.66	7,035.62	98.33	-295.48
Book Value Growth (%)	--	10.05	0.43	22.52	-35.86	-11.08

Valuation Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Price / Earnings	439.27	50.26	698.34	--	--	--
Price / Book Value	2.34	4.59	2.99	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	262.82	40.19	627.44	3.26	-10.40	-34.38
Close Price (₹)	30.25	58.59	34.71	--	--	--
High Price (₹)	53.49	108.15	50.14	--	--	--
Low Price (₹)	20.10	28.36	20.65	--	--	--
Market Cap (₹ Cr)	9.22	17.90	10.60	--	--	--

Solvency Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Debt to Equity	--	--	--	--	--	0.34
Short term debt to equity ratio	--	--	--	--	--	--
Current Ratio	8.40	5.73	3.68	2.89	5.31	0.19
Quick Ratio	7.52	5.11	3.68	2.89	5.31	0.19
Interest Coverage	--	2,845.31	24.40	225.30	0.96	-1.80

Operating Efficiency Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16
Debtors to sales (%)	1,073.15	262.40	1,532.71	81.45	--	31.20
Asset Turnover	0.05	0.19	0.04	0.66	0.01	0.03
Receivable days	--	1,026.01	5,248.74	297.29	--	146.98
Inventory Days	--	122.93	--	--	--	--
Payable days	--	554.30	--	70.37	3,716.00	231.43
Cash Conversion Cycle	--	594.64	--	226.92	-3,716.00	-84.45

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.